Interestingly, CXCR1/2 inhibition reversed the chemoresistance induced by MSCs, as tumor progression was abolished when mice were treated with a mix of carboplatin and CXCR1/2 inhibitor (reparixin) (Figure 4D and E). This evidence concerns the gene CXCR1 and neoplasm.